ScienceDex / Researcher record
Mehta, Manav
- Gel4med, Inc. (no department on record)
From the FY2016 NIH awards this investigator leads as contact PI. The department is the award's.
NIH Funding · FY2016
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2016 | $223,369 | 1 | #30,348 |
| 2017 | $814,871 | 3 | #8,964 |
| 2019 | $648,852 | 2 | #14,745 |
| 2021 | $1,009,790 | 2 | #9,095 |
| 2022 | $50,000 | 1 | #45,951 |
| 2023 | $2,319,996 | 2 | #2,905 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2016 · selected1 record
- FY20173 records
- FY20192 records
- FY20212 records
- FY20221 record
- FY20232 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2016 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2016 award records by amount
NIH award records listing Mehta, Manav as a PI. Multi-PI records show the full award amount for context.
- 1R43GM117858-01R43Contact PIFlowable antimicrobial skin scaffolding matrix that promotes regeneration$223.4Kaward amount
Award organization
Organizations that administered FY2016 awards listing Mehta, Manav as a PI.
FY2016 award administered by Gel4med, Inc. (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2016First NIH AwardGel4med, Inc.
- 2017$500K Cumulative Funding
- 2017$1M Cumulative Funding
- 2017Entered Top 50% NationallyRanked #8964
- 2021$2M Cumulative Funding
- 2023$5M Cumulative Funding
- 2023Entered Top 25% NationallyRanked #2905